Maravai Lifesciences Holdings (MRVI) Change in Inventory (2020 - 2026)
Maravai Lifesciences Holdings (MRVI) recorded quarterly Change in Inventory of -$33000.0 in Q1 2026, up 98.93% quarter-over-quarter from -$3.1 million in Q4 2025, and up 92.65% on a YoY basis from -$17129.5 in Q1 2025.
Maravai Lifesciences Holdings (MRVI) Change in Inventory (2020 - 2026) Analysis & Trends
Maravai Lifesciences Holdings' Change in Inventory history runs 7 years deep, the most recent figure standing at -$33000.0 for Q1 2026.
- In Q1 2026, Change in Inventory rose 92.65% year-over-year to -$33000.0; the TTM figure through Mar 2026 stood at -$7.6 million (down 126283.33% YoY), while the FY2025 annual figure was -$8.0 million, down 2021.75% from the prior year.
- Change in Inventory was -$33000.0 for Q1 2026 at Maravai Lifesciences Holdings, up from -$3.1 million in the prior quarter.
- In the past five years, Change in Inventory ranged from a high of $8.7 million in Q2 2022 to a low of -$19.3 million in Q4 2022.
- Historically, Change in Inventory has averaged -$1.1 million across 5 years, with a median of -$452000.0 in 2024.
- The sharpest annual moves came in 2023 and 2025: Change in Inventory soared 381.68% in 2023, then plunged 584.07% in 2025.
- A 5-year view of Change in Inventory shows it stood at -$19.3 million in 2022, then soared by 111.33% to $2.2 million in 2023, then plunged by 120.7% to -$452000.0 in 2024, then slumped by 584.07% to -$3.1 million in 2025, then soared by 98.93% to -$33000.0 in 2026.
- The last three Change in Inventory figures came in at -$33000.0 (Q1 2026), -$3.1 million (Q4 2025), and -$1.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 788,338.31 Bn | 788,338.28 Bn | - | - |
| 2 | Belite Bio | 56,560.00 Bn | 56,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,329.30 Bn | 17,329.30 Bn | - | 51,468.00 |
| 4 | Legend Biotech | 3,341.00 Bn | 3,340.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,727.91 Bn | 1,727.91 Bn | - | - |
| 6 | Evaxion A | 1,536.68 Bn | 1,536.67 Bn | - | - |
| 7 | Psyence Biomedical | 238.34 Bn | 238.33 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.42 Bn | 106.17 Bn | 2.59 Bn | 97.70 Mn |
| 9 | Abivax | 95.45 Bn | 95.45 Bn | - | - |
| 10 | Maravai Lifesciences Holdings | 747.50 Mn | 739.10 Mn | 33.70 Mn | -33,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33,000.00 |
| Mar 31, 2026 | -33,000.00 |
| Dec 31, 2025 | -3.09 Mn |
| Dec 31, 2025 | -3.09 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Sep 30, 2025 | -1.35 Mn |
| Jun 30, 2025 | -3.11 Mn |
| Jun 30, 2025 | -3.11 Mn |
| Mar 31, 2025 | -449,000.00 |
| Mar 31, 2025 | -449,000.00 |
| Dec 31, 2024 | -452,000.00 |
| Dec 31, 2024 | -452,000.00 |
| Sep 30, 2024 | 1.60 Mn |
| Sep 30, 2024 | 1.60 Mn |
| Jun 30, 2024 | -702,000.00 |
| Jun 30, 2024 | -702,000.00 |
| Mar 31, 2024 | -820,000.00 |
| Mar 31, 2024 | -820,000.00 |
| Dec 31, 2023 | 2.18 Mn |
| Dec 31, 2023 | 2.18 Mn |